Sign In
Buy IART
$18.58
-0.210 (-1.12%)
At Close: Jul 13, 2026
Here's Why Integra LifeSciences (IART) is a Strong Value Stock
10:41am, Thursday, 09'th Jul 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Integra (IART) Is Attractively Priced Despite Fast-paced Momentum
09:56am, Thursday, 09'th Jul 2026
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Integra (IART) could be a great choice. It is one of the several stocks that passed
IART or SONVY: Which Is the Better Value Stock Right Now?
12:40pm, Monday, 06'th Jul 2026
Investors looking for stocks in the Medical - Instruments sector might want to consider either Integra LifeSciences (IART) or SONOVA HOLDING (SONVY). But which of these two stocks is more attractive t
Integra LifeSciences Appoints Topaz Kirlew Chief Regulatory Officer
08:30am, Thursday, 02'nd Jul 2026
Kirlew will lead Integra's global regulatory affairs organization as the company continues to strengthen quality, compliance, and execution. Kirlew will lead Integra's global regulatory affairs organi
Integra Lifesciences Holdings Corp (IART) Shares Fall 4.2% -- What GF Score of 71 Tells Investors
09:27pm, Tuesday, 30'th Jun 2026
On June 30, 2026, Integra Lifesciences Holdings Corp (IART) shares fell 4.2% to $17.98, amid a 52-week trading range of $8.70 to $18.92. This decline comes desp
Bet on These 3 Stocks as Broker Rating Upgrades Signal Upside
09:36am, Tuesday, 23'rd Jun 2026
MITT, SVM and IART stand out as broker rating upgrades, earnings growth forecasts and screen criteria point to potential upside.
Integra LifeSciences Announces Key Executive Appointments
08:00am, Tuesday, 23'rd Jun 2026
PRINCETON, N.J., June 23, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Corporation Holdings (Nasdaq: IART), a global leader in medical technology, today announced several leadership appointments with
Here's Why Integra LifeSciences (IART) is a Strong Momentum Stock
10:56am, Monday, 22'nd Jun 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Integra (IART) Shows Fast-paced Momentum But Is Still a Bargain Stock
09:55am, Monday, 22'nd Jun 2026
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Integra (IART) could be a great choice. It is one of the several stocks that passed
Integra LifeSciences: New Beginning
01:37am, Monday, 22'nd Jun 2026
Integra LifeSciences specializes in neuro-related surgical devices and regenerative tissue technologies. The tissue reconstruction segment, featuring collagen-based products like Integra Skin and PriM
IART vs. SONVY: Which Stock Is the Better Value Option?
12:41pm, Friday, 19'th Jun 2026
Investors interested in Medical - Instruments stocks are likely familiar with Integra LifeSciences (IART) and SONOVA HOLDING (SONVY). But which of these two stocks is more attractive to value investor
Integra LifeSciences Holdings Corporation (IART) Hits Fresh High: Is There Still Room to Run?
10:15am, Tuesday, 16'th Jun 2026
Integra (IART) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference
08:30am, Monday, 15'th Jun 2026
PRINCETON, N.J., June 15, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Bob Davis, executive vice
Why Integra LifeSciences (IART) is a Top Value Stock for the Long-Term
10:41am, Tuesday, 09'th Jun 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Is Integra (IART) Up 15% Since Last Earnings Report?
12:36pm, Thursday, 04'th Jun 2026
Integra (IART) reported earnings 30 days ago. What's next for the stock?
